Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
Open Access
- 1 October 2020
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (2) , e660-e674
Abstract
Context 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting This was a multicenter retrospective study using information collected from 3 predominant centers. Patients A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder.Keywords
Funding Information
- Canadian Institutes of Health Research (201610PJT-377869, MOP-G2-341146-159133-BRIDG, 201603PJT-148695, 2017-2022)
- Fonds de Recherche du Québec–Santé
- Compute Canada
- McGill Faculty of Medicine
- Ministry of National Education, Republic of Indonesia
- BC Children’s Hospital Foundation
- National Institute of Neurological Disorders and Stroke (R01NS082094)
This publication has 24 references indexed in Scilit:
- More Than Hypomyelination in Pol-III DisorderJournal of Neuropathology & Experimental Neurology, 2013
- 4H Syndrome With Late-Onset Growth Hormone Deficiency Caused by POLR3A MutationsArchives of Neurology, 2012
- Recessive Mutations in POLR3B, Encoding the Second Largest Subunit of Pol III, Cause a Rare Hypomyelinating LeukodystrophyThe American Journal of Human Genetics, 2011
- Mutations of POLR3A Encoding a Catalytic Subunit of RNA Polymerase Pol III Cause a Recessive Hypomyelinating LeukodystrophyThe American Journal of Human Genetics, 2011
- Magnetic resonance imaging pattern recognition in hypomyelinating disordersBrain, 2010
- New Case of 4H Syndrome and a Review of the LiteraturePediatric Neurology, 2010
- Invited Article: An MRI-based approach to the diagnosis of white matter disordersNeurology, 2009
- Microcephaly SyndromesSeminars in Pediatric Neurology, 2007
- Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspectsEuropean Journal of Endocrinology, 2004
- Prevalence and aetiology of hypothyroidism in the youngArchives of Disease in Childhood, 2000